WILLIAMS AND JENSEN, PLLC for SANOFI, U.S.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
HCR-General education about federal policies impacting pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, Affordable Care Act issues). MMM-General education about policies impacting pharmaceutical development, approval, reimbursement. MED-General education about FDA approval policies and NIH research activities. TAX-Tax reform, including the orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER New | Sch C. Treasury; LD , Rep Scott McInnis |
| SUSAN HIRSCHMANN New | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER New | Shrd Employee, Ofc of Speaker & Ofc of VA 7; Sr. Policy Adv, Majority Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox |
| ANDREW JONES New | Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep Lujan |
| NICHOLAS KARELLAS New | LA to Senator Bond; Tax Counsel, Rep Jenkins |
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate committees on Aging and Gov. Affairs. |
Taxation/Internal Revenue Code TAX
HCR-General education about federal policies impacting pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, Affordable Care Act issues). MMM-General education about policies impacting pharmaceutical development, approval, reimbursement. MED-General education about FDA approval policies and NIH research activities. TAX-Tax reform, including the orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER New | Sch C. Treasury; LD , Rep Scott McInnis |
| SUSAN HIRSCHMANN New | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER New | Shrd Employee, Ofc of Speaker & Ofc of VA 7; Sr. Policy Adv, Majority Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox |
| ANDREW JONES New | Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep Lujan |
| NICHOLAS KARELLAS New | LA to Senator Bond; Tax Counsel, Rep Jenkins |
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate committees on Aging and Gov. Affairs. |
Medicare/Medicaid MMM
HCR-General education about federal policies impacting pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, Affordable Care Act issues). MMM-General education about policies impacting pharmaceutical development, approval, reimbursement. MED-General education about FDA approval policies and NIH research activities. TAX-Tax reform, including the orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER New | Sch C. Treasury; LD , Rep Scott McInnis |
| SUSAN HIRSCHMANN New | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER New | Shrd Employee, Ofc of Speaker & Ofc of VA 7; Sr. Policy Adv, Majority Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox |
| ANDREW JONES New | Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep Lujan |
| NICHOLAS KARELLAS New | LA to Senator Bond; Tax Counsel, Rep Jenkins |
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate committees on Aging and Gov. Affairs. |
Health Issues HCR
HCR-General education about federal policies impacting pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, Affordable Care Act issues). MMM-General education about policies impacting pharmaceutical development, approval, reimbursement. MED-General education about FDA approval policies and NIH research activities. TAX-Tax reform, including the orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER New | Sch C. Treasury; LD , Rep Scott McInnis |
| SUSAN HIRSCHMANN New | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER New | Shrd Employee, Ofc of Speaker & Ofc of VA 7; Sr. Policy Adv, Majority Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox |
| ANDREW JONES New | Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep Lujan |
| NICHOLAS KARELLAS New | LA to Senator Bond; Tax Counsel, Rep Jenkins |
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate committees on Aging and Gov. Affairs. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI SA | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.